(台北場)From clinical trials to real-world practice in multiple myeloma: Proteasome inhibition in the continuous treatment paradigm

日期:107年8月18日(六)17:00:00

時間:2018-08-18的17:00至19:10

類型:甲類

積分:2

主辦單位:台灣武田藥品工業股份有限公司、中華民國血液病學會

會議地點:板橋凱薩大飯店_宴會樓2樓, 如意 CDE廳

交通指南:

節目表:
武田邀請學會合作舉辦8/17-8/18 MM研討會,有興趣參加者,敬請於8/13前上網登記,謝謝!

Chair’s welcome and introduction
Multiple Myeloma in Taiwan: Where Are We Now and Where Are We Going With the Care of MM Patients?
- Continuous therapy in multiple myeloma: A critical review and current perspectives
- Q&As
- Proteasome inhibition in multiple myeloma therapy: Current evidence and future research
- Q&As
Real-world effectiveness of Ninlaro: local case sharing
Panel discussion
Summary and close